127 related articles for article (PubMed ID: 4013136)
1. A pasteurized antithrombin III concentrate for clinical use.
Smith JK; Winkelman L; Evans DR; Haddon ME; Sims G
Vox Sang; 1985; 48(6):325-32. PubMed ID: 4013136
[TBL] [Abstract][Full Text] [Related]
2. Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.
Wickerhauser M; Williams C; Mercer J
Vox Sang; 1979; 36(5):281-93. PubMed ID: 462917
[TBL] [Abstract][Full Text] [Related]
3. A single-step method for the isolation of antithrombin III.
Wickerhauser M; Williams C
Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
[TBL] [Abstract][Full Text] [Related]
4. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
Biescas H; Gensana M; Fernández J; Ristol P; Massot M; Watson E; Vericat F
Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
[TBL] [Abstract][Full Text] [Related]
5. Pasteurisation induced changes in an antithrombin III concentrate.
Winkelman L; Haddon ME
Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
[TBL] [Abstract][Full Text] [Related]
6. Virus safety of pasteurized antithrombin III concentrate.
Roggendorf M; Delvos U; Nováková-Banet A
Thromb Haemost; 1991 Feb; 65(2):212. PubMed ID: 1647061
[No Abstract] [Full Text] [Related]
7. [Preparation and characterization of an antithrombin III concentrate].
Dornheim G; Schön R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):870-7. PubMed ID: 6187640
[TBL] [Abstract][Full Text] [Related]
8. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
D'Souza S; Ananthakrishnan R
Aust J Exp Biol Med Sci; 1979 Jun; 57(3):245-50. PubMed ID: 316999
[TBL] [Abstract][Full Text] [Related]
9. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion.
Brandt P
Thromb Res; 1981 Apr 1-15; 22(1-2):15-24. PubMed ID: 7292437
[TBL] [Abstract][Full Text] [Related]
10. Purification and properties of guinea pig antithrombin III.
Heck L; Rosenberg R; Remold H
Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
[TBL] [Abstract][Full Text] [Related]
11. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN
Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
[TBL] [Abstract][Full Text] [Related]
12. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency.
Harper PL; Park GR; Carrell RW
Transfus Med; 1996 Mar; 6(1):45-50. PubMed ID: 8696447
[TBL] [Abstract][Full Text] [Related]
13. Manufacturing process of anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance.
Morrica A; Nardini C; Falbo A; Bailey AC; Bucci E
Biologicals; 2003 Sep; 31(3):165-73. PubMed ID: 12935804
[TBL] [Abstract][Full Text] [Related]
14. Purification and large-scale preparation of antithrombin III.
Hoffman DL
Am J Med; 1989 Sep; 87(3B):23S-26S. PubMed ID: 2801726
[TBL] [Abstract][Full Text] [Related]
15. Large-scale production and properties of human plasma-derived activated Factor VII concentrate.
Tomokiyo K; Yano H; Imamura M; Nakano Y; Nakagaki T; Ogata Y; Terano T; Miyamoto S; Funatsu A
Vox Sang; 2003 Jan; 84(1):54-64. PubMed ID: 12542734
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
17. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
Chang WS; Harper PL
Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
19. Treatment of congenital antithrombin III deficiency with concentrates.
Mannucci PM; Boyer C; Wolf M; Tripodi A; Larrieu MJ
Br J Haematol; 1982 Mar; 50(3):531-5. PubMed ID: 7066204
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III concentrates.
Menache D
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1115-20. PubMed ID: 1400075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
